secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0001493152-24-007408
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio adopts Code of Business Conduct and Ethics on Feb 14, 2024
----------------------------------------------------------------------

- Company adopted a Code of Business Conduct and Ethics effective February 14, 2024.
- Code applies to all officers, directors, and employees, including CEO and CFO.
- Code filed as Exhibit 14.1 to this 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224007408/0001493152-24-007408-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224007408/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-007408

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer